Clin2
NCT07729462Possibly a fitNot yet recruiting

Rimegepant for preventing chronic migraine

Preventive Treatment of Migraine

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have had chronic migraine (15 or more headache days per month) for at least 1 year.
  • Your migraine started before age 50 and became chronic before age 65.
  • Your migraine attacks last between 4 and 72 hours if untreated.
  • You have not used rimegepant for migraine prevention before.
  • You have not failed more than 4 prior preventive medications, including at least 2 different types.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07609914Recruiting· Phase 4
Safety study of an extra dose of rimegepant for migraine

This study tests whether taking an additional dose of rimegepant (a migraine medicine you may already use) is safe and helpful for adults with migraine. Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist—a type of medicine that blocks a protein involved in migraine pain.

Canoga Park, California
NCT06728345Not yet recruiting
Rimegepant for preventing migraine in women in China

This study tests if the drug rimegepant can help prevent migraine attacks in women. It aims to see how well it works in real life in China.

NCT06409832Recruiting
Study of rimegepant for migraine prevention

This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.

Florence, Florence
NCT07301008Recruiting· Phase 4
Rimegepant to prevent predictable trigger-induced migraines

This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.

McLean, Virginia
NCT05156398Recruiting· Phase 3
Rimegepant to prevent migraine attacks in children

This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.

Fort Smith, Arkansas
NCT06641466Recruiting· Phase 3
Study of Rimegepant for preventing menstrual migraine in women

This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.

Phoenix, Arizona

Hear when a new Preventive Treatment of Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.